Alliangana, D.M.: "Effects of beta-carotene, flavonoid quercetin and quinacrine on cell proliferation and lipid peroxidation breakdown products in BHK-21 cells". East Afr Med J. 1996;73:752-757.

Amella, M. et. al.: "Inhibitio of mast cell histamine release by flavanoids and bioflavanoids". Planta medica 51:16-20, 1985

Balasubramanian, S., Govindasamy, S.: "Inhibitory effect of dietary flavonol quercetin on 7,12-dimethylbenz[a]anthracene-induced hamster buccal pouch carcinogenesis". Carcinogenesis. 1996;17:877-879.

Constant J. Alcohol, ischemic heart disease, and the French paradox. Coron Artery Dis. 1997;8:645-649.

Cross, H.J., Tilby, M., Chipman, J.K., et al.: "Effect of quercetin on the genotoxic potential of cisplatin". Int. J. Cancer. 1996;66:404-408.

El Attar, T.M., Virji, A.S.: "Modulating effect of resveratrol and quercetin on oral cancer cell growth and proliferation". Anticancer Drugs. 1999;10:187-193.

Frankel, E.N., Waterhouse, A.L., Kinsella, J.E.: "Inhibition of human LDL oxidation by resveratrol". Lancet. 1993; 341:1103-1104.

Friedman, M., Smith, G.A.: "Factors which facilitate inactivation of quercetin mutagenicity". Adv. Exp. Med. Biol. 1984;177:527-544.

Hayek, T., Fuhrman, B., Vaya, J.: "Reduced progression of atherosclerosis in apolipoprotein E-deficient mice following consumption of red wine, or its polyphenols quercetin or catechin, is associated with reduced susceptibility of LDL to oxidation and aggregation". Arterioscler Thromb Vasc Biol. 1997;17:2744-2752.

Hoffman, R., Graham, L., Newlands, E.S.: "Enhanced anti-proliferative action of busulphan by quercetin on the human leukaemia cell line K562". Br. J. Cancer. 1989; 59:347-348.

Kaul, T.N., Middleton, E. Jr., Ogra, P.L.: "Antiviral effect of flavonoids on human viruses". J Med Virol. 1985;15:71-79.

Keli, S.O., Hertog, M.G., Feskens, E.J., et al.: "Dietary flavonoids, antioxidant vitamins, and incidence of stroke: the Zupthen study". Arch Intern Med. 1996;156:637-642.

Middleton, E. Jr.: "Effect of flavonoids on basophil histamine release and other secretory systems". Prog Clin Biol Res. 1986;213:493-506.

Middleton, E., Drzewiecki, G.: "Naturally occurring flavanoids and human basophil histamin release". Int. Arch. Allergy Applied Immuno 77:155-7, 1985

Musci, I., Pragai, B.M.: "Inhibition of virus multiplication and alteration of cyclic AMP level in cell cultures by flavonoids". Experientia. 1985;41:930-931.

Ogasawara, H, Middleton, E. Jr.: "Effect of selected flavonoids on histamine release (HR) and hydrogen peroxide (H2O2) generation by human leukocytes" [abstract]. J. Allergy Clin. Immunol. 1985;75(suppl):184.

Pearce, M. et. al.: "Mucosal mast cell. III. Effect of quercitin and other flavanoids on antigen induced histamine secretion from rat intestinal mast cell". J. Allergy Clin. Immunol. 73:819-23, 1984

Rodriguez, L.V., Janzen, N., Raz, S,, et al.: "Treatment of interstitial cystitis with a quercetin containing compound: a preliminary, double-blind placebo control trial". Presented at: American Urological Association 2001 Annual Meeting; June 2-7, 2001; Anaheim, Calif.

Shoskes, D.A., Zeitlin, S.I., Shahed, A., et al.: "Quercetin in men with category III chronic prostatitis: a preliminary prospective, double-blind, placebo-controlled trial". Urology. 1999;54:960-963.

So, F.V., Guthrie, N., Chambers, A.F., Moussa, M., Carroll, K.K: "Inhibition of human breast cancer cell proliferation and delay of mammary tumorigenesis by flavonoids and citrus juices". Nutr. Cancer 1996;26(2):167-81 Department of Pharmacology and Toxicology, University of Western Ontario, London, Canada.

Stavric, B.: "Quercetin in our diet: from potent mutagen to probable anticarcinogen". Clin. Biochem. 1994;27:245-248.

Strick, R., Strissel, P.L., Borgers, S. et al.: "Dietary bioflavonoids induce cleavage in the MLL gene and may contribute to infant leukemia". Proc. Natl. Acad. Sci. 2000;97:4790-4795.

Varma, S.D., Mizuno, A., Kinoshita, J.H.: "Diabetic cataracts and flavonoids". Science. 1977;195:205-206.

Yoshida, M., Yamamoto, M., Nikaido, T.: "Quercetin arrests human leukemic T-cells in late G1 phase of the cell cycle". Cancer Res. 1992;52:6676-6681.

Yoshimoto T, Furukawa M, Yamamoto S, et al. Flavonoids: potent inhibitors of arachidonate 5-lipoxygenase. Biochem Biophys Res Commun. 1983;116:612-618.